{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:27:17Z","timestamp":1791959237928,"version":"4.3.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Limited data exist on adherence to fecal calprotectin (FCP) testing in patients with inflammatory bowel disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Completion rates for patients who had at least one FCP test ordered (n = 3082) and a subgroup with C-reactive protein, complete blood count, and Clostridium difficile tests also ordered (n = 1563) were analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>More patients completed blood than stool tests, with FCP having the poorest adherence of all tests analyzed. Older patients had higher FCP completion rates. No differences were noted in completion rates across age, gender, or ethnicity for blood tests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Further studies are needed to develop strategies that improve the uptake of FCP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/crocol\/otab028","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T19:33:28Z","timestamp":1621452808000},"source":"Crossref","is-referenced-by-count":18,"title":["Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2561-3826","authenticated-orcid":false,"given":"Nidah S","family":"Khakoo","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Miami School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayanna","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni A","family":"Roldan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Al Khoury","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Quintero","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar R","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Kerman","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana M","family":"Damas","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T","family":"Abreu","sequence":"additional","affiliation":[{"name":"Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine , Miami, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"1","key":"2022111812362344100_CIT0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365521.2014.987809","article-title":"Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease","volume":"50","author":"Sipponen","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"2022111812362344100_CIT0002","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-Reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"2022111812362344100_CIT0003","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2015\/950286","article-title":"Fecal calprotectin use in inflammatory bowel disease and beyond: a mini-review","volume":"29","author":"Alibrahim","year":"2015","journal-title":"Can J Gastroenterol Hepatol."},{"key":"2022111812362344100_CIT0004","first-page":"197","article-title":"The use of fecal calprotectin as a biomarker in gastrointestinal disease","volume-title":"Expert Rev Gastroenterol Hepatol","author":"Burri","year":"2014"},{"issue":"3","key":"2022111812362344100_CIT0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MIB.0000000000000652","article-title":"Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn\u2019s disease","volume":"22","author":"Zittan","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2022111812362344100_CIT0006","first-page":"33","article-title":"Does fecal calprotectin predict short-term relapse after stopping TNF\u03b1-blocking agents in inflammatory bowel disease patients in deep remission?","volume":"9","author":"Molander","year":"2015","journal-title":"J Crohns Colitis."},{"key":"2022111812362344100_CIT0007","doi-asserted-by":"crossref","DOI":"10.1016\/bs.acc.2018.07.005","volume-title":"Fecal Calprotectin","author":"Ayling","year":"2018"},{"key":"2022111812362344100_CIT0008","first-page":"2333392814547129","article-title":"A1C testing and its sociodemographic predictors: implications for diabetes self-management programs","volume":"1","author":"Nepal","year":"2014","journal-title":"Health Serv Res Manag Epidemiol"},{"key":"2022111812362344100_CIT0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/clc.20175","article-title":"Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients","volume":"31(1)","author":"Pamboukian","year":"2008","journal-title":"Clin Cardiol."},{"issue":"6","key":"2022111812362344100_CIT0010","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11606-018-4820-0","article-title":"Factors affecting adherence in a pragmatic trial of annual fecal immunochemical testing for colorectal cancer","volume":"34","author":"Nielson","year":"2019","journal-title":"J Gen Intern Med."},{"key":"2022111812362344100_CIT0011","article-title":"Histology and endoscopy discordance in inflammatory bowel disease varies by phenotype and location of disease","author":"Serigado","journal-title":"ACG 2019;114(p S441)."},{"issue":"8","key":"2022111812362344100_CIT0012","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm Bowel Dis."},{"issue":"10114","key":"2022111812362344100_CIT0013","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet."},{"issue":"11","key":"2022111812362344100_CIT0014","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.105.591271","article-title":"Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation."},{"issue":"5","key":"2022111812362344100_CIT0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2050640616686517","article-title":"Compliance with the faecal calprotectin test in patients with inflammatory bowel disease","volume":"5","author":"Mar\u00e9chal","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"2022111812362344100_CIT0016","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/00365521.2018.1527394","article-title":"Patients\u2019 perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey","volume":"53","author":"Kalla","year":"2018","journal-title":"Scand J Gastroenterol."},{"issue":"9","key":"2022111812362344100_CIT0017","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/gut.26.9.955","article-title":"111Indium autologous granulocytes in the detection of inflammatory bowel disease","volume":"26","author":"Saverymuttu","year":"1985","journal-title":"Gut."}],"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otab028\/38657822\/otab028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/3\/3\/otab028\/47118907\/otab028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/3\/3\/otab028\/47118907\/otab028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:37:58Z","timestamp":1668775078000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otab028\/6300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otab028","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,6,16]]},"article-number":"otab028"}}